Using the Visible Blue Light of Argon Laser Technology for Treatment of Jaundice in Infants.

Objective: To determine the effect of visible blue wavelengths of argon laser beams in reducing bilirubin levels in newborns with jaundice. Background: Newborn jaundice ("hyperbilirubinemia") results from increased bilirubin concentrations in the skin and blood. Sunlight, comprising various light rays, is commonly used to treat this condition by breaking down bilirubin molecules. Other phototherapy techniques, including lamp phototherapy, are also employed. Methods: An experimental study was conducted on six male infants (5 to 15 days old) with jaundice at a hospital. These infants were exposed to blue-violet scattered light from an argon laser with a wavelength of 450 nm. Results: The concentration of bilirubin in these infants decreased following exposure to the argon laser light. The 450 nm wavelength effectively absorbs bilirubin, facilitating its breakdown. Conclusion: The study demonstrates the effectiveness of using argon laser with visible blue light in reducing bilirubin levels in infants with jaundice. This finding encourages health professionals to consider argon laser therapy as a treatment option for neonatal jaundice. [ABSTRACT FROM AUTHOR]